Published Research Summaries (click "Search" in Menu to filter)

Myofacial pelvic pain patients report high effectiveness of cannabinoids

While the vast majority reported effectiveness for MPP pain relief, almost 97% reported an improvement in their quality of life. About 92% reported improvements in their sleep and almost 74% were able to reduce other medications after initiating cannabinoid treatment.

Patients with anxiety, chronic pain, PTSD and other conditions show improvements with cannabis medicines

This study used self-reported, observational patient data to assess cannabis' effectiveness for any condition and overall quality of life changes. It was published online in the journal Drug Science in May 2023.

CBD helps dementia patients; the 'usual medical treatment' not so much

While it was a small study, the results are very encouraging. The CBD group showed significant improvement while the group receiving the 'usual medical treatment' showed little to no improvement.

After 10 years, older HIV patients show better cognitive performance with occasional cannabis use

Over a period of up to 10 years, this study tracked levels of cannabis use and cognitive and everyday function in 297 older adults (age 50 to 84) with HIV.

Edible cannabis' effects on cancer patients - pain, cognition, quality of life

Participants were asked to take only one EDIBLE cannabis product of their choice for the entire two week period. During that time, patients took products as they needed them (ad libitum). The most common cancer type was lung, followed by colon and breast cancer.

Treatment-resistant patients say their quality of life improves with cannabinoid medicine

This original investigation examined the effects of cannabis treatment on health-related quality of life (HRQoL) in more than 3,000 patients diagnosed with several chronic, treatment-resistant conditions.

Topical CBD inhibits periodontitis

This experiment looked for the effects of CBD on common molecular markers for periodontal disease. They concluded: "CBD can be considered as a therapeutic agent for periodontitis."

Elderly mice that vape hemp and cannabis every day see benefits

This study examined the neurobiological effects of cannabis on the aging brain using a mouse model. Elderly mice were divided into three groups and exposed to cannabis flower vaporized at 210°C (410°F) in a Volcano vaporizer.

Cannabis and chronic refractory pain, including arthritis

Australian patients were prescribed cannabinoid medicines with varying ratios of THC to CBD. They generally observed that a more balanced THC:CBD ratio (similar amounts of THC and CBD) demonstrated the best results for chronic pain, including arthritis.

IBD and cannabis: a new review study

29 studies published between 2012 and 2022 were included in this review article. The studies reviewed included some randomized controlled trials (RCT) and preclinical in vivo research studies.

Terpenes activate cannabinoid CB1 receptors, just like THC

This study's goal was to determine if, and how much, different terpenes affect cannabinoid CB1 receptors with and without THC. It was published in the journal Biochemical Pharmacology in June 2023.

Study shows cannabis is NOT linked to psychosis

Cannabis use has been associated with psychosis from the very early years of prohibition. This study was developed to help provide better evidence. It was published in the journal Psychiatry and Clinical Neurosciences in April 2023

CBGA helps reduce harm in kidney disease models

"We conclude that CBGA and CBD possess reno-protective properties, with CBGA having a higher efficacy, likely due to its dual anti-inflammatory and anti-fibrotic effects"

Very small doses of sublingual CBD + THC spray helps with Type 2 Diabetes

This study measured the effects of very small CBD + THC sublingual doses on the lipid profile and glycemic state of diabetic patients. The randomized, double blind placebo controlled study included 50 diabetic patients who were treated daily for 8 weeks.

87% see Parkinson's Disease symptoms improve with medical cannabis

A retrospective study to explore the impact of medical cannabis on the treatment of Parkinson's Disease symptoms. It was published in April 2023 in the journal Clinical Neuropharmacology.

CBG shows promise for the treatment of MS

This study examined the in vitro and in vivo effects of CBG on multiple sclerosis (MS) markers and was published in the journal Biomolecules in February 2023.

Multi-cannabinoid medicine seems better than isolate for Alzheimer's Disease

"Research suggests that cannabinoid treatments involving a combination of THC and CBD and other cannabinoids can produce greater therapeutic outcomes and less adverse effects than treatment with purified cannabinoid isolates."

CBD helps reduce daytime drowsiness and "Low T"

The goal of this study was to determine if daily self-dosed CBD would have an impact on daytime drowsiness, low total testosterone, and liver test results. It was published online in the journal Medical Cannabis & Cannabinoids in March 2023.

1 … 4 5 6 7 8 … 21

ads:

WARNING: Everyone has unique biochemistry, preexisting conditions, and mental state. Almost all medicinal and psychotropic products can cause adverse side effects in some people. The same is true with cannabinoid products, especially when they contain psychotropic cannabinoids like THC. Be very careful. Reported or statistically implied adverse effects include, but are not limited to: cannabis hyperemesis syndrome (CHS), adverse cardiovascular events (stroke, heart attack), arrhythmia, psychosis, and addiction (cannabis use disorder, or CUD).

Your cart is currently empty.

Enable cookies to use the shopping cart

t: e

(-)

Item Quantity

Special instructions